XATRAL XL TABLET 10 MG [SIN11579P]

Product Info

XATRAL XL TABLET 10 MG

[SIN11579P]

Indication

Therapeutic indications
Treatment of the functional symptoms of benign prostatic hypertrophy (BPH). Adjuvant treatment to a catheter in first episode of acute urinary retention (AUR) related to benign prostatic hypertrophy (BPH).

Dosing

Posology and method of administration
Benign Prostatic Hypertrophy (BPH):
The recommended dosage is one 10-mg tablet per day, to be taken immediately after the evening meal.
Adjuvant treatment to a catheter in the first episode of acute urinary retention related to benign prostatic hypertrophy:
The recommended dosage is one 10-mg tablet per day, to be taken after a meal, from the first day of catheterization onwards.
The treatment is administered for 3 to 4 days, i.e. 2 to 3 days while the catheter is in place and 1 day after it is removed.
The tablet must be swallowed whole with a glass of water (see Special warnings and special precautions for use – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

Contraindications

Contraindications
This medicine must not be administered in the following situations:

• Hypersensitivity to alfuzosin and/or any of the other ingredients;

• Orthostatic hypotension,

• Hepatic failure;

• Severe renal failure (creatinine clearance <30 ml/min),

• Concomitant administration of ritonavir alone or in combination with ombitasvir/paritaprevir, lopinavir or nirmatrelvir (see Interaction with other medicinal products and other forms of interaction – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).

• Concomitant administration with potent CYP3A4 inhibitors